Discontinued — last reported Q4 '18

Products & Services · Impairment

TECFIDERA — Impairment

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ4 2018
Rolls up toImpairment Charges

How to read this metric

An increase indicates a loss of value or reduced commercial outlook for the product, while a decrease suggests stable or improving asset valuation.

Detailed definition

This metric represents the non-cash charge recognized when the carrying value of an intangible asset or product-related...

Peer comparison

Peers in the pharmaceutical industry frequently report similar impairment charges for specific drug assets following generic entry or clinical trial failures.

Metric ID: biib_segment_tecfidera_impairment

Similar Metrics at Other Companies

United Therapeutics logo
United TherapeuticsUTHRView metric
IR
Ingersoll RandIRView metric
Teledyne Technologies logo
Teledyne TechnologiesTDYView metric
Teledyne Technologies logo
Teledyne TechnologiesTDYView metric
Teledyne Technologies logo
Teledyne TechnologiesTDYView metric
TechnipFMC logo
TechnipFMCFTIView metric

Frequently Asked Questions

What does tecfidera — impairment mean?
A reduction in the recorded value of a product asset due to a decline in its expected future profitability.